Who owns Contineum Therapeutics, Inc.?
Institutional ownership of CTNM from SEC Form 13F filings across 72 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
72
13F holders
$357.9M
value, 2026 filers
58.1%
of shares outstanding (21.9M sh)
24
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of CTNM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 2.8M | $46.6M | 0.9% | 7.6% | 0.0% |
| 2 | Jupiter Topco LLCNEW | 2.7M | $44.8M | 0.0% | 7.3% | new |
| 3 | BlackRock, Inc. | 2.1M | $33.8M | 0.0% | 5.5% | +208.5% |
| 4 | FRANKLIN RESOURCES INC | 1.8M | $30.1M | 0.0% | 4.9% | 0.0% |
| 5 | Balyasny Asset Management L.P. | 1.5M | $25.0M | 0.0% | 4% | -9.7% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $21.7M | 0.0% | 3.5% | -45.6% |
| 7 | FMR LLC | 1.0M | $17.0M | 0.0% | 2.8% | +27.6% |
| 8 | MILLENNIUM MANAGEMENT LLC | 931,709 | $15.3M | 0.0% | 2.5% | -39.3% |
| 9 | GREAT POINT PARTNERS LLC | 921,481 | $15.1M | 2.9% | 2.4% | +15.2% |
| 10 | Longaeva Partners L.P. | 812,757 | $13.3M | 0.3% | 2.2% | +11.0% |
| 11 | SECTORAL ASSET MANAGEMENT INC | 727,587 | $11.9M | 8.3% | 1.9% | 0.0% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 693,188 | $11.4M | 0.0% | 1.8% | +145.8% |
| 13 | GOLDMAN SACHS GROUP INC | 497,255 | $8.2M | 0.0% | 1.3% | +61.9% |
| 14 | CITADEL ADVISORS LLC | 396,354 | $6.5M | 0.0% | 1.1% | +13.2% |
| 15 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 328,000 | $5.4M | 0.0% | 0.9% | new |
| 16 | SILVERARC CAPITAL MANAGEMENT, LLC | 296,135 | $4.9M | 0.5% | 0.8% | -1.9% |
| 17 | NORTHERN TRUST CORP | 277,804 | $4.6M | 0.0% | 0.7% | +321.4% |
| 18 | BOOTHBAY FUND MANAGEMENT, LLC | 222,329 | $3.6M | 0.0% | 0.6% | 0.0% |
| 19 | Sixth Street Partners Management Company, L.P.NEW | 214,082 | $3.5M | 0.6% | 0.6% | new |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 214,082 | $3.5M | 0.0% | 0.6% | +48.7% |
| 21 | Qube Research & Technologies Ltd | 182,413 | $3.0M | 0.0% | 0.5% | -21.6% |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 180,302 | $3.0M | 0.0% | 0.5% | new |
| 23 | VANGUARD FIDUCIARY TRUST CO | 177,281 | $2.9M | 0.0% | 0.5% | +15.2% |
| 24 | WELLINGTON MANAGEMENT GROUP LLP | 150,797 | $2.5M | 0.0% | 0.4% | +171.2% |
| 25 | UBS Group AG | 130,642 | $2.1M | 0.0% | 0.3% | -43.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.